top of page

HOOK

HOOKIPA Pharma Inc.

Price

chg

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

low api

52 wk hi

high api

Cash

$140.8M

Burn Rate (Qtr)

N/A

Mkt Cap

mkt cap api

Avg Volume

volume api

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Create Free Account Now

Loading Catalysts...

search in progress

Pipeline powered by

HOOK

BPIQ_Logo_RGB-01.jpg

Company Profile

HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on a proprietary arenavirus platform that is designed to reprogram the body’s immune system.

Recent Posts

See what the community is saying - click to see full post.

Q1 '22 EcoR1 Newly Added Stocks (hedge fund)

ASCO 2022 Annual Meeting (American Society of Clinical Oncology) - Clinical Trial Presentations

Big-Mover™ Stocks to Watch July/August 2021

ASCO 2021 Investor Hub - Presented Posters

ASCO 2021 Investor Hub - Updated

PDSB HPV Cancer Data Generates Buzz at ASCO21

bottom of page